Resmetirom Reduces Liver, CV Risk Factors in NASH With Cirrhosis
After 1 year of therapy with the oral thyromimetic, patients with well-compensated NASH cirrhosis had significant improvements in both liver- and heart-related risk factors.
Stay updated with breaking news from Stephen Harrison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After 1 year of therapy with the oral thyromimetic, patients with well-compensated NASH cirrhosis had significant improvements in both liver- and heart-related risk factors.
Late-breaking abstract selected by AASLD as one of the "Best of the Liver Meeting" for 2022 Phase 2 for PXL065 in NASH achieved the primary efficacy endpoint for liver fat content reduction
They'll resume performing in the spring.
Noam Galai/Getty ImagesFEVER 333 won't be performing live again until next year. In an Instagram post, frontman Jason Aalon Butler writes that the band "will be
Woolworths Group Limited (OTCPK:WOLWF) Q1 2023 Results Conference Call November 02, 2022 07:30 PM ET Company Participants Brad Banducci - Chief Executive Officer and Managing Director...